Request for Covid-19 Impact Assessment of this Report
Organ care system market for lung forecast to have a huge progress in the estimated period. The rising cases of lung disease not only in the elderly population but in all age groups will give a boost to this market. The lung transplant brings control on the disease consequences.
Organ care system market for Lung Drivers:
Rising cases of elderly population, adaptation of bad activities and lack of physical activity boost to the growth organ care system market for Lung.
According to WHO, “The old age population is estimated to rise up to 2 billion by the end of 2050”, globally old age population is increasing at a higher rate especially in the countries like U.S., UK and Japan”. The rise in the geriatric population, unhealthy life style among the huge population, addicted to unhealthy habits such as smoking, and due to the absence of physical activities are the major factors which drives the market for organ care lungs system, which increase the market size in the forecast period.
Market Restrains:
Cold Storage can be a severe threat to the growth of organ care system market for Lung.
As per survey “In the U.S. 77% of the donated lungs went unutilized due to the shortage of cold storage”. The restrains in the OCS market for lung is the Cold storage. There is a high chance of having complication after the transplantation which adversely affect the patients’ health due to cold storage. Moreover, there is a lot of scarcity for donor and even after getting the donor, the donor has to undergo through lot of medical test to calculate the strength and other factors related to health for donating lungs, these are the biggest restraints in the OCS market for lung. Additionally, the success ratio for the survival of the patient is not as successful like kidney or liver.
Organ care system market for Lung, by Handling:
Trolley based is predicted to be most profitable till the end of 2026
The organ care system market for Lung is divided into 2 parts Portable and Trolley based. Trolley based is the transplantation device which is most widely used and available in most of the centers. Trolley based is expected to grow at a CAGR of 19.7% and generating a revenue of $3354.6 thousand by 2026. Portable based is efficient in terms of increasing organ efficiency, helps in healthier organ transplantation, portable in transportation within time frame are the main factor for the growth of the portable based. It is expected to generate a revenue of $2254.4 thousand by 2026 at a CAGR of 18%.
Organ care system market for Lung, by Region:
North America region will have enormous opportunities for the market investors to grow over the coming years
In 2018, North America is considered to be the largest OCS market size for lung. It is anticipated to grow at $2760.2 thousand by 2026 at a CAGR of 24.0%. The market is projected to grow due to the increase in the lung diseases and presence of large old population. Similarly, the Europe is also considered the biggest OCS lung market followed by North America, which holds the major size in 2018 by $493.8 thousand and is projected to grow at a 24.0% CAGR by generating revenue of $2760.2 thousand by 2026.
Due to the presence of lesser number of diagnostic center and appropriate medical facilities, Asia Pacific is considered as the biggest OCS lung market size in future which is expected to grow at a 18% CAGR by generating a revenue of $975.3 by 2026.
Key participants in the global Organ care system market for Lung Scope:
The organ care system market players are Transmedics, Xvivo Perfusion AB, Organ Assist B.V. and among others. The major key players are investing in their research and development to develop a new product with advanced technology can be considered to boost the overall organ care system market for Lung. TransMedics have invested around $50 million and have supported the organ care system that is developed, which improves the organs function after the body have been removed.
Aspect Particulars
Historical Market Estimations 2016-2018
Base Year for Market Estimation 2018
Forecast timeline for Market Projection 2019-2026
Geographical Scope North America, Europe, Asia-Pacific, LAMEA
Segmentation by Handling • Portable
• Trolley Based
Key Countries covered U.S., Canada, Germany, France, Spain, Russia, Japan, China, India, South Korea, Australia, Brazil, and Saudi Arabia
Key Companies Profiled • Transmedics
• Xvivo Perfusion AB
• Organ Assist B.V
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.4.1. Assumptions
1.4.2. Forecast parameters
1.5. Data sources
1.5.1. Primary
1.5.2. Secondary
2. Executive Summary
2.1. 360° summary
2.2. Mode of Handling
3. Market overview
3.1. Market segmentation & definitions
3.2. Key takeaways
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of consumers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of new entrants
3.3.4. Threat of substitutes
3.3.5. Competitive rivalry in the market
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Technology landscape
3.6. Regulatory landscape
3.7. Patent landscape
3.8. Market value chain analysis
3.8.1. Stress point analysis
3.9. Strategic overview
4. Organ Care System Market for Liver, by Mode of Handling
4.1. Portable
4.1.1. Market size and forecast, by region, 2016-2026
4.1.2. Comparative market share analysis, 2018 & 2026
4.2. Trolley Based
4.2.1. Market size and forecast, by region, 2016-2026
4.2.2. Comparative market share analysis, 2018 & 2026
5. Organ Care System Market of Liver, by Region
5.1. North America
5.1.1. Market size and forecast, by type of handling, 2016-2026
5.1.2. Market size and forecast, by country, 2016-2026
5.1.3. Comparative market share analysis, 2018 & 2026
5.1.4. U.S.
5.1.4.1. Market size and forecast, by type of handling,2016-2026
5.1.4.2. Comparative market share analysis, 2018 & 2026
5.1.5. Canada
5.1.5.1. Market size and forecast, by type of handling,2016-2026
5.1.5.2. Comparative market share analysis, 2018 & 2026
5.1.6. Mexico
5.1.6.1. Market size and forecast, by type of handling,2016-2026
5.1.6.2. Comparative market share analysis, 2018 & 2026
5.2. Europe
5.2.1. Market size and forecast, by type of handling,2016-2026
5.2.2. Market size and forecast, by country, 2016-2026
5.2.3. Comparative market share analysis, 2018 & 2026
5.2.4. Germany
5.2.4.1. Market size and forecast, by type of handling,2016-2026
5.2.4.2. Comparative market share analysis, 2018 & 2026
5.2.5. Spain
5.2.5.1. Market size and forecast, by type of handling,2016-2026
5.2.5.2. Comparative market share analysis, 2018 & 2026
5.2.6. France
5.2.6.1. Market size and forecast, by type of handling,2016-2026
5.2.6.2. Comparative market share analysis, 2018 & 2026
5.2.7. Italy
5.2.7.1. Market size and forecast, by type of handling,2016-2026
5.2.7.2. Comparative market share analysis, 2018 & 2026
5.2.8. Rest of the Europe
5.2.8.1. Market size and forecast, by type of handling,2016-2026
5.2.8.2. Comparative market share analysis, 2018 & 2026
5.3. Asia-Pacific
5.3.1. Market size and forecast, by type of handling,2016-2026
5.3.2. Market size and forecast, by country, 2016-2026
5.3.3. Comparative market share analysis, 2018 & 2026
5.3.4. China
5.3.4.1. Market size and forecast, by type of handling,2016-2026
5.3.4.2. Comparative market share analysis, 2018 & 2026
5.3.5. Japan
5.3.5.1. Market size and forecast, by type of handling,2016-2026
5.3.5.2. Comparative market share analysis, 2018 & 2026
5.3.6. India
5.3.6.1. Market size and forecast, by type of handling,2016-2026
5.3.6.2. Comparative market share analysis, 2018 & 2026
5.3.7. Australia
5.3.7.1. Market size and forecast, by type of handling,2016-2026
5.3.7.2. Comparative market share analysis, 2018 & 2026
5.3.8. South Korea
5.3.8.1. Market size and forecast, by type of handling,2016-2026
5.3.8.2. Comparative market share analysis, 2018 & 2026
5.3.9. Rest of the Asia Pacific
5.3.9.1. Market size and forecast, by type of handling,2016-2026
5.3.9.2. Comparative market share analysis, 2018 & 2026
5.4. LAMEA
5.4.1. Market size and forecast, by type of handling,2016-2026
5.4.2. Market size and forecast, by country, 2016-2026
5.4.3. Comparative market share analysis, 2018 & 2026
5.4.4. Brazil
5.4.4.1. Market size and forecast, by type of handling,2016-2026
5.4.4.2. Comparative market share analysis, 2018 & 2026
5.4.5. Saudi Arabia
5.4.5.1. Market size and forecast, by type of handling,2016-2026
5.4.5.2. Comparative market share analysis, 2018 & 2026
5.4.6. South Africa
5.4.6.1. Market size and forecast, by type of handling,2016-2026
5.4.6.2. Comparative market share analysis, 2018 & 2026
5.4.7. Rest of LAMEA
5.4.7.1. Market size and forecast, by type of handling,2016-2026
5.4.7.2. Comparative market share analysis, 2018 & 2026
6. Company profiles
6.1. TransMedics Inc.
6.1.1. Business overview
6.1.2. Financial performance
6.1.3. Product portfolio
6.1.4. Recent strategic moves & developments
6.1.5. SWOT analysis
6.2. Bridge to life and Ltd.
6.2.1. Business overview
6.2.2. Financial performance
6.2.3. Product portfolio
6.2.4. Recent strategic moves & developments
6.2.5. SWOT analysis
6.3. Paragonix Technologies Inc.
6.3.1. Business overview
6.3.2. Financial performance
6.3.3. Product portfolio
6.3.4. Recent strategic moves & developments
6.3.5. SWOT analysis
6.4. Preservation Solution Inc.,
6.4.1. Business overview
6.4.2. Financial performance
6.4.3. Product portfolio
6.4.4. Recent strategic moves & developments
6.4.5. SWOT analysis
6.5. Organ Transport System Inc.
6.5.1. Business overview
6.5.2. Financial performance
6.5.3. Product portfolio
6.5.4. Recent strategic moves & developments
6.5.5. SWOT analysis
6.6. Preservation Solution Inc.
6.6.1. Business overview
6.6.2. Financial performance
6.6.3. Product portfolio
6.6.4. Recent strategic moves & developments
6.6.5. SWOT analysis
6.7. XVIVO Perfusion AB
6.7.1. Business overview
6.7.2. Financial performance
6.7.3. Product portfolio
6.7.4. Recent strategic moves & developments
6.7.5. SWOT analysis
6.8. Organ Assist B.V.
6.8.1. Business overview
6.8.2. Financial performance
6.8.3. Product portfolio
6.8.4. Recent strategic moves & developments
6.8.5. SWOT analysis
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...